Venkataprasanth Reddy, MD
Hematology & Oncology · Beckley, WVNPI 1033190301
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $1,110 of the $1,545 with a category attached, or 71.8%. Daiichi Sankyo Inc. accounts for 71.8% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2021 at $1,110 and has fallen 82.7% since, to $192 in 2025.
Across 15 payments — averaging $103.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Daiichi Sankyo Inc.$1K
- Abbott$163
- Takeda Pharmaceuticals U.S.A., Inc.$35
- AbbVie$27
- Genentech USA, Inc.$26
- Sobi, Inc$24
- plus $160 from 8 others
What the payments were for
- Consulting fees$1,11072%
- Food & beverage$43528%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Daiichi Sankyo Inc. | 1 | $1,110 |
| Abbott | 2 | $163 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $35 |
| AbbVie | 1 | $27 |
| Genentech USA, Inc. | 1 | $26 |
| Sobi, Inc | 1 | $24 |
| Springworks Therapeutics, Inc. | 1 | $23 |
| Johnson & Johnson | 1 | $22 |
| Merck | 1 | $22 |
| Lilly USA, LLC | 1 | $21 |
| Regeneron Healthcare Solutions, Inc. | 1 | $19 |
| Servier Pharmaceuticals LLC | 1 | $18 |
| Pfizer | 1 | $18 |
| Novocure Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Enhertu$1,110
- AMPLATZER AMULET$143
How this compares
$1,545 in reported general payments places this provider in the 55th percentile of 72 hematology & oncology providers in West Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other hematology & oncology in Beckley
- Odeth Barrett-CampbellBeckley$3K
- Damian SilberminsHuntington$277K
- Abraham KanateMorgantown$169K
- Salman OsmanBridgeport$118K
- Ashkan EmadiMorgantown$88K
- Konstantinos SdrimasMorgantown$81K
- Arvinder BirHuntington$74K
- Bhavana BhatnagarWheeling$72K
- Ihtishaam QaziMorgantown$18K
- Matias ValsecchiHuntington$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.